A randomized controlled trial of SOF/VEL/VOX with or without ribavirin for retreatment of chronic hepatitis C. El-Kassas M, Emadeldeen M, Hassany M, Esmat G, et al. J Hepatol 2023 Apr 21:S0168-8278(23)00234-9. doi: 10.1016/j.jhep.2023.

Read + Share

Amedeo Smart

Independent Medical Education

El-Kassas M, Emadeldeen M, Hassany M, Esmat G, et al. A randomized controlled trial of SOF/VEL/VOX with or without ribavirin for retreatment of chronic hepatitis C. J Hepatol 2023 Apr 21:S0168-8278(23)00234-9. doi: 10.1016/j.jhep.2023.
PMID: 37088312